Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM Integration for Burning Mouth Syndrome
NCT04189367Phase 3Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jun 2020
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in burning mouth syndrome (BMS) (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoints: Global Perceived Effect at 12 weeks and Numerical Rating Scale at 12 weeks. Status: unknown.
02
Conditions
burning mouth syndrome (BMS)
Beyond the preview
Go deeper on NCT04189367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189367.